APN.JO Overview

Company Profile

Related stocks

4015.SR • Saudi Arabia

Jamjoom Pharmaceuticals Factory

128 SAR

2.39B USD 1Y -19.2%

2230.SR • Saudi Arabia

Saudi Chemical Co.

7.22 SAR

1.62B USD 1Y +0.6%

2070.SR • Saudi Arabia

Saudi Pharmaceutical Industries

30.46 SAR

968.19M USD 1Y +2.8%

ECILC.IS • Türkiye

ECZACIBASI ILAC

62.3 TRY

866.66M USD 1Y -32%

4016.SR • Saudi Arabia

Middle East Pharmaceutical Indu

63.25 SAR

589.55M USD 1Y -17.4%

128940.KS • South Korea

HanmiPharm

480,500 KRW

4.55B USD 1Y +35.5%

600329.SS • China

TIANJIN PHARMACEUTICAL DA REN T

35.8 CNY

4.13B USD 1Y -17.6%

RGC • Hong Kong SAR China

Regencell Bioscience Holdings L

7.35 USD

3.64B USD 1Y -60.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Africa

Region

Africa & Middle East

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

36.7% p.a.

Max Drawdown (5Y)

-63.9%

Sharpe Ratio (5Y)

-0.28

Beta Factor

0.52

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 1173.8 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.7% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -79.9% in the extended horizon.